Insider Transactions in Q2 2025 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2025
|
Matthew R. Henn |
SELL
Open market or private sale
|
Direct |
77
-1.73%
|
$539
$7.28 P/Share
|
|
May 16
2025
|
Eric D. Shaff CEO and President |
SELL
Open market or private sale
|
Direct |
220
-2.13%
|
$1,540
$7.28 P/Share
|
|
May 16
2025
|
Teresa L. Young |
SELL
Open market or private sale
|
Direct |
63
-1.23%
|
$441
$7.28 P/Share
|
|
May 15
2025
|
Matthew R. Henn |
BUY
Exercise of conversion of derivative security
|
Direct |
238
+2.63%
|
-
|
|
May 15
2025
|
Thomas Des Rosier Chief Legal Officer and EVP |
SELL
Open market or private sale
|
Direct |
79
-1.07%
|
$553
$7.28 P/Share
|
|
May 15
2025
|
Thomas Des Rosier Chief Legal Officer and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
244
+1.64%
|
-
|
|
May 15
2025
|
Eric D. Shaff CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
721
+3.43%
|
-
|
|
May 15
2025
|
Teresa L. Young |
BUY
Exercise of conversion of derivative security
|
Direct |
231
+2.23%
|
-
|